Skip to content
PolarisQB
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us
PolarisQB Logo
  • Why Quantum
    • Quantum Computing Today
    • Quantum vs. Traditional Screening
    • Quantum Computing vs. AI
  • QuADD Solutions
    • Hits & Leads
    • Joint Development
    • Pipeline
    • Platform
  • Who We Serve
    • Pharma
    • Biotech
    • Agriculture
    • CROs
  • Resources
    • Blog
    • Whitepapers
    • Webinars
    • Publications
  • Company
    • About Us
    • Customers
    • Partners
    • News
    • Team
  • Contact Us

Partners

  • Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design
    August 19th, 2024· 2 min·
    Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design

    PolarisQB is happy to announce the integration of Virtual Libraries and

  • Reconnecting with Partners at JPM
    February 12th, 2024· 2.8 min·
    Reconnecting with Partners at JPM

    JPM week in San Francisco is always a busy time

  • PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform
    January 16th, 2024· 2 min·
    PolarisQB and Scientist.com Partner to Offer Online Access to Quantum-Aided Drug Design, the first Quantum-Enabled Drug Discovery Platform

    POLARISqb, the first company to build quantum-enabled molecular optimization tools

  • Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases
    June 4th, 2021· 2.5 min·
    Auransa and PolarisQB Enter Research Collaboration to find Treatments for Neglected Women’s Diseases

    PALO ALTO, Calif. and DURHAM, N.C., June 04, 2021 /PRNewswire/ -- Auransa, Inc., an artificial

  • September 25th, 2020· 0.5 min·
    Disrupting and Accelerating Drug Discovery

    [vc_row][vc_column][vc_video link="https://www.youtube.com/watch?v=mttMA9yrisE&feature=emb_logo"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]Fujitsu and PolarisQB are partnering to create a platform that uses

Search
Recent Posts
  • PolarisQB Demonstrates Advances in Drug Safety Prediction with Quantum-Inspired AI, Enabling Earlier Elimination of Toxic Compounds from Discovery Pipeline April 14, 2026
  • Polaris Quantum Biotech has been selected as a 2026 winner of the Cleveland Clinic Quantum Innovation Catalyzer Program April 14, 2026
  • Quantum-Enhanced Drug Metabolism Prediction: Achieving More Reliable CYP3A4 Substrate Classification February 10, 2026
Categories
  • Blog (16)
  • News (48)

Why Quantum

Quantum Computing Today
Quantum vs. Traditional Screening
Quantum vs. AI

QuADD Solutions

Hits & Leads
Joint Development
Pipeline
Platform

Who We Serve

Pharma
Biotech
Agriculture
CROs

Resources

Blog
Whitepapers
Webinars
Publications

Company

About Us
Customers
Partners
News
Team
Contact

212 W Main St
Suite 200 PMB 205
Durham, NC 27701

info@polarisqb.com
919.200.0592

© 2026 All Rights Reserved | Privacy Policy | Terms of Use

Page load link
Go to Top